Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis, Gastroenterology, vol.132, issue.7, pp.2557-2576, 2007. ,
DOI : 10.1053/j.gastro.2007.04.061
Globocan 2008 v2.0, Cancer incidence and Mortality Worldwide: IARC CancerBase No10 [Internet], International Agency for Research on Cancer. Available, 2010. ,
Diagnosis and Treatment of Hepatocellular Carcinoma, Gastroenterology, vol.134, issue.6, 2008. ,
DOI : 10.1053/j.gastro.2008.02.090
TGF?? Signaling: Receptors, Transducers, and Mad Proteins, Cell, vol.85, issue.7, pp.947-95081296, 1996. ,
DOI : 10.1016/S0092-8674(00)81296-9
TGF?? in Cancer, Cell, vol.134, issue.2, pp.215-230, 2008. ,
DOI : 10.1016/j.cell.2008.07.001
Smad2 and Smad4 gene mutations in hepatocellular carcinoma, Oncogene, vol.18, issue.34, pp.4879-4883, 1999. ,
DOI : 10.1038/sj.onc.1202866
Liver stem cells and hepatocellular carcinoma, Hepatology, vol.10, issue.1, pp.318-329, 2009. ,
DOI : 10.1002/hep.22704
Disruption of transforming growth factor-beta signaling in ELF beta-spectrindeficient mice, Science, vol.299, 2003. ,
Integration of Ras subeffector signaling in TGF-?? mediated late stage hepatocarcinogenesis, Carcinogenesis, vol.26, issue.5, pp.931-942, 2005. ,
DOI : 10.1093/carcin/bgi043
Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta, Hepatogastroenterology, vol.51, pp.396-400, 2004. ,
Abrogation of TGF signaling in hepatocellular carcinoma by overexpression of antagonistic Smad7, Hepatology, vol.34, p.665 ,
Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor-suppression in rat hepatocellular carcinoma Factors of transforming growth factor beta signalling are coregulated in human hepatocellular carcinoma, Hepatology Virchows Arch, vol.49, issue.445, pp.1944-1953, 2004. ,
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene, EMBO J, vol.17, p.9606191, 1998. ,
Roles of Bone Morphogenetic Protein Type I Receptors and Smad Proteins in Osteoblast and Chondroblast Differentiation, Molecular Biology of the Cell, vol.10, issue.11, 1999. ,
DOI : 10.1091/mbc.10.11.3801
Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor ?? (TGF-??)-induced Activation of Smad7: THE TGF-?? RESPONSE ELEMENT OF THE PROMOTER REQUIRES FUNCTIONAL Smad BINDING ELEMENT AND E-BOX SEQUENCES FOR TRANSCRIPTIONAL REGULATION, Journal of Biological Chemistry, vol.275, issue.38, pp.29308-29317, 2000. ,
DOI : 10.1074/jbc.M003282200
Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer, Hepatology, vol.47, 2008. ,
Smad phosphoisoform signaling specificity: the right place at the right time, Carcinogenesis, vol.32, issue.11, pp.1578-1588, 2011. ,
DOI : 10.1093/carcin/bgr172
RING finger-dependent ubiquitination by PRAJA is dependent on TGF-?? and potentially defines the functional status of the tumor suppressor ELF, Oncogene, vol.8, issue.5, pp.693-705, 2006. ,
DOI : 10.1038/23293
TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF, Biochem Biophys Res Commun, vol.344, 2006. ,
The role of PRAJA and ELF in TGF-?? signaling and gastric cancer, Cancer Biology & Therapy, vol.4, issue.7, pp.694-699, 2005. ,
DOI : 10.4161/cbt.4.7.2015
Disruption of transforming growth factor-beta signaling through betaspectrin ELF leads to hepatocellular cancer through cyclin D1 activation, Oncogene, vol.26, p.17546056, 2007. ,
Alterations in the Smad pathway in human cancers, Frontiers in Bioscience, vol.17, issue.1, pp.1281-1293, 2012. ,
DOI : 10.2741/3986
Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma, Oncology, vol.82, issue.1, pp.11-18, 2012. ,
DOI : 10.1159/000335605
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis, Lab Invest, vol.90, p.20531292, 2010. ,
Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-?? Signaling in Hepatocarcinogenesis, Digestive Diseases, vol.29, issue.3, 2011. ,
DOI : 10.1159/000327560
Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias, Clinical Oral Investigations, vol.29, issue.3, pp.921-953, 2012. ,
DOI : 10.1007/s00784-012-0756-7
Overexpression of the TGF-?? antagonist Smad7 in endometrial cancer, Gynecologic Oncology, vol.96, issue.2, pp.368-373, 2005. ,
DOI : 10.1016/j.ygyno.2004.10.006
Involvement of programmed cell death 4 in transforming growth factor- beta1-induced apoptosis in human hepatocellular carcinoma, Oncogene, vol.25, p.16682950, 2006. ,
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-??-dependent Apoptosis, Journal of Biological Chemistry, vol.275, issue.46, pp.36295-36302, 2000. ,
DOI : 10.1074/jbc.M006023200
Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation, Molecular and Cellular Biology, vol.26, issue.2, pp.654-667, 2006. ,
DOI : 10.1128/MCB.26.2.654-667.2006
[Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis], Nan Fang Yi Ke Da Xue Xue Bao, vol.28, pp.1848-1852, 2008. ,
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor ?? blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma, Hepatology, vol.15, issue.2, pp.523-534, 2010. ,
DOI : 10.1002/hep.23285
Human Hepatocellular Carcinoma (HCC) Cells Require Both ??3??1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion, Laboratory Investigation, vol.65, issue.4, pp.613-627, 2001. ,
DOI : 10.1083/jcb.146.6.1375
Hepatic stem cells and transforming growth factor ?? in hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, vol.25, issue.9, pp.530-538 ,
DOI : 10.1038/nrgastro.2012.114
Hepatocyte-Specific Smad7 Expression Attenuates TGF-?????Mediated Fibrogenesis and Protects Against Liver Damage, Gastroenterology, vol.135, issue.2, pp.642-659, 2008. ,
DOI : 10.1053/j.gastro.2008.04.038
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis, Hepatology, vol.49, 2009. ,
Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes, Hepatology, vol.331, issue.6, pp.2127-2136, 2010. ,
DOI : 10.1002/hep.23930
Distinct role of endocytosis for Smad and non-Smad TGF-beta signalling regulation in hepatocytes, J Hepatol, vol.55, p.21184784, 2011. ,
Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture, Hepatology, vol.31, issue.Suppl 1, 2012. ,
DOI : 10.1002/hep.24712
Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis, Frontiers in Bioscience, vol.16, issue.1, pp.815-837, 2011. ,
DOI : 10.2741/3722
Dissecting the effect of targeting the epidermal growth factor receptor on TGF-??-induced-apoptosis in human hepatocellular carcinoma cells, Journal of Hepatology, vol.55, issue.2, pp.351-358, 2011. ,
DOI : 10.1016/j.jhep.2010.10.041
Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF-??-Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4, Cancer Research, vol.69, issue.19, pp.7595-7602, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-1482
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor ?? signaling, promoting cirrhosis and hepatocellular carcinoma, Hepatology, vol.420, issue.1, pp.48-57, 2007. ,
DOI : 10.1002/hep.21672
Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-?? signaling from tumor suppression to oncogenesis in early chronic hepatitis B, Hepatology, vol.281, issue.Suppl, pp.1203-1217, 2009. ,
DOI : 10.1002/hep.22765
Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma, International Journal of Cancer, vol.44, issue.2, pp.141-146, 1983. ,
DOI : 10.1002/ijc.2910320202
Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection, Cancer, vol.32, issue.5, pp.1054-106010, 1989. ,
DOI : 10.1002/1097-0142(19890901)64:5<1054::AID-CNCR2820640516>3.0.CO;2-X
Targeting heat shock protein 90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma, Hepatology, vol.353, issue.1, pp.102-112, 2009. ,
DOI : 10.1002/hep.22912